No reduction in surgical time or radiation exposure with new vertebral access devices in kyphoplasty

Arch Orthop Trauma Surg. 2019 Nov;139(11):1571-1577.

OTA 2019: Feasibility trial comparing IFF to DFR for distal femoral fractures in osteoporotic elders

Better clinicoradiological results at 3 years with SpineJack vertebral augmentation vs BPK for VCFs

Osteoporos Int. 2019 Mar;30(3):637-645. doi: 10.1007/s00198-018-4773-5

Lower risk of cement leakage with unilateral vs. bilateral vertebral augmentation for OVCFs

World Neurosurg. 2019 Feb;122:342-348. doi: 10.1016/j.wneu.2018.10.143

Rigid- vs. soft thoracolumbosacral orthosis following osteoporotic vertebral compression fracture

J Clin Med. 2019 Feb 6;8(2). pii: E198. doi: 10.3390/jcm8020198

Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level

J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y

Incidence of falls reduced following balance training in patients with osteoporosis

J Rehabil Med. 2018 Jul 17;50(7):577-581. doi: 10.2340/16501977-2334

Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis

Climacteric. 2018 Apr;21(2):189-195

Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls

Expert Opin Drug Saf. 2018 Apr;17(4):413-428

AAOS2018: Abaloparatide 80ug daily reduces rate of major NVFs in osteoporotic postmenopausal women

Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture

Osteoporos Int. 2016 Nov;27(11):3289-3300

Effects of teriparatide versus risedronate following pertrochanteric fracture fixation

J Bone Joint Surg Am. 2016 Nov 16;98(22):1868-1878

Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis

N Engl J Med. 2016 Oct 20;375(16):1532-1543

Efficacy of vertebroplasty vs sham for acute vertebral fracture in patients over 60

Lancet. 2016 Oct 1;388(10052):1408-1416

The effect of eldecalcitol on balence and strength in women with osteoporosis

J Bone Miner Metab. 2016 Sep;34(5):547-54

Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates

J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70

Combination therapy improves site-specific BMD vs. teriparatide & denosumab monotherapies

J Clin Densitom. 2016 Jul-Sep;19(3):346-51

Vertebral augmentation using SpineJack vs. balloon kyphoplasty for osteoporotic VCF

Osteoporos Int. 2016 Jun;27(6):2047-55

Immediate effects on bone metabolism biomarkers noted with resistance training and walking

BMC Musculoskelet Disord. 2016 Jun 8;17(1):254

Network meta-analysis of anti-osteoporosis therapies for oral glucocorticoid users

Osteoporos Int. 2016 Jun;27(6):1989-98